CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | DOBMEIER ERIC Director | Grant or award | +57,000 | 116,500 | ||
| 2023-05-31 | DOBMEIER ERIC Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2023-05-31 | MALLIK AMEET Director | Grant or award | +57,000 | 77,500 | ||
| 2023-05-31 | MALLIK AMEET Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2023-05-31 | HEIDEN WILLIAM K Director | Grant or award | +57,000 | 109,000 | ||
| 2023-05-31 | HEIDEN WILLIAM K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2023-05-16 | Banard Charlene A. EVP, Chief Technical Officer | Sale | −19,040 | $2.04 | $39K | 276,010 |
| 2023-05-16 | Murugan Amar EVP, Chief Legal Officer | Sale | −7,404 | $2.04 | $15K | 271,930 |
| 2023-05-16 | Murugan Amar EVP, Chief Legal Officer | Sale | −985 | $2.04 | $2K | 270,945 |
| 2023-05-16 | Touchon Pascal President and CEO | Sale | −29,766 | $2.04 | $61K | 720,962 |
| 2023-05-16 | Hyllengren Eric J SVP, CFO | Sale | −6,199 | $2.04 | $13K | 227,861 |
| 2023-05-16 | Hyllengren Eric J SVP, CFO | Sale | −1,719 | $2.04 | $4K | 226,142 |
| 2023-03-02 | Touchon Pascal President and CEO | Sale | −15,679 | $3.63 | $57K | 750,728 |
| 2023-03-02 | Murugan Amar SVP, GC & Secretary | Sale | −4,221 | $3.63 | $15K | 279,334 |
| 2023-03-02 | Koppikar Utpal Chief Financial Officer | Sale | −6,871 | $3.63 | $25K | 181,978 |
| 2023-03-02 | Dupont Jakob EVP, Head of R&D | Sale | −5,074 | $3.63 | $18K | 290,794 |
| 2023-03-01 | Banard Charlene A. EVP, Chief Technical Officer | Grant or award | +139,700 | 295,050 | ||
| 2023-03-01 | Banard Charlene A. EVP, Chief Technical Officer | Grant or award · Employee Stock Option (Right to Buy) | +314,325 | 314,325 | ||
| 2023-03-01 | Touchon Pascal President and CEO | Grant or award | +324,711 | 766,407 | ||
| 2023-03-01 | Touchon Pascal President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +730,600 | 730,600 |
Page 8 of 17 · 334 trades